Back
Inspire Medical Systems Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
4
INSP
Inspire Medical Systems
Last Price:
139.19
Seasonality Move:
5.64%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.82
Seasonality Move:
-0.9%
Sell
4
Inspire Medical Systems (INSP)
is a Sell
Is Inspire Medical Systems a Buy, Sell or Hold?
- The current Inspire Medical Systems [INSP] share price is $135.30. The Score for INSP is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
- INSP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INSP Stock Price Chart
What is Inspire Medical Systems's stock price today?
-
The Inspire Medical Systems share price today is $135.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSP is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
INSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.42 | Sell |
Relative Strength Index (14 RSI): | 29.77 | Sell |
Chaikin Money Flow: | -1596626 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (150.82 - 165.3) | Sell |
Bollinger Bands (100): | (164.23 - 224.55) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.74 | Sell |
Relative Strength Index (14 RSI): | 45.16 | Sell |
Chaikin Money Flow: | -377368 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.89 - 42.13) | Sell |
Bollinger Bands (100): | (40.93 - 48.81) | Sell |
INSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 161.63 | Sell |
20-day SMA: | 158.62 | Sell |
50-day SMA: | 187.46 | Sell |
200-day SMA: | 185.19 | Sell |
8-day EMA: | 157.39 | Sell |
20-day EMA: | 162.09 | Sell |
50-day EMA: | 176.53 | Sell |
200-day EMA: | 196.76 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.13 | Sell |
20-day SMA: | 40.38 | Sell |
50-day SMA: | 41.72 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.68 | Sell |
20-day EMA: | 40.43 | Sell |
50-day EMA: | 41.92 | Sell |
200-day EMA: | 43.42 | Sell |
Inspire Medical Systems Earnings Growth & INSP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.60 per share, an increase next quarter of $0.05 per share, an increase this year of $1.45 per share, and an increase next year of $0.61 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Inspire Medical Systems Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |